| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/08/2007 | EP1392728B1 Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases |
| 08/08/2007 | EP1381387B1 Use of stimulated peripheral blood mononuclear cells for treating cancerous diseases |
| 08/08/2007 | EP1267616B1 Methods of increasing hair growth by wnt polypeptide |
| 08/08/2007 | EP1108035B1 Treatment of cervical cancer |
| 08/08/2007 | EP1100538B1 Kvlqt1 - a long qt syndrome |
| 08/08/2007 | EP1092772B1 Antibody against lar phosphatase subunit |
| 08/08/2007 | EP1075523B1 Structural proteins of fish pancreatic disease virus and uses thereof |
| 08/08/2007 | CN1330754C Ligand 0(cluding antibody) for display aimed-at endocrine cell reactivity |
| 08/08/2007 | CN1330668C Antibodies to insulin-like growth factor I receptor |
| 08/08/2007 | CN1330664C Expression technology for proteins containing hybrid isotype antibody moiety |
| 08/08/2007 | CN1330640C Substituted bicyclic derivatives for the treatment of abnormal cell growth |
| 08/08/2007 | CN1330377C Peptide-base immunotherapeutic agent for allergic diseases |
| 08/08/2007 | CN1330376C Recombinant Borrel virus combined vaccine |
| 08/08/2007 | CN1330375C Humanized antibodies that recognize verotoxin II and cell line producing same |
| 08/08/2007 | CN1330308C Use of 4-pyridylmethylphthalazines for cancer treatment |
| 08/08/2007 | CN101014698A Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates |
| 08/08/2007 | CN101014625A Novel anti-IGF-IR antibodies and uses thereof |
| 08/08/2007 | CN101014624A Antigen binding proteins directed against scavenger receptor b1 that inhibit hcv replication |
| 08/08/2007 | CN101014623A Dr5抗体及其用途 Dr5 antibodies and their use |
| 08/08/2007 | CN101014621A Treatment of bacterial infections |
| 08/08/2007 | CN101014620A Antibodies against clostridium difficile toxins and uses thereof |
| 08/08/2007 | CN101014619A Optimized fc variants |
| 08/08/2007 | CN101014613A Chimpanzee adenovirus vaccine carriers |
| 08/08/2007 | CN101014386A Antagonist anti-cd40 monoclonal antibodies and methods for their use |
| 08/08/2007 | CN101014367A Adjuvant therapy with the use of anti-glypican 3 antibody |
| 08/08/2007 | CN101014366A Therapy of platinum-resistant cancer |
| 08/08/2007 | CN101014365A Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody |
| 08/08/2007 | CN101014364A Anti-ngf antibodies and methods using same |
| 08/08/2007 | CN101014363A Vaccine for periodontal disease |
| 08/08/2007 | CN101014362A Human complement c3 derivatives with cobra venom factor-like function |
| 08/08/2007 | CN101012458A Expression system |
| 08/08/2007 | CN101012454A Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleotide sequences |
| 08/08/2007 | CN101012445A Colloidal gold immune chromatography fast differential diagnosis kit of chicken avian influenza vaccine immunity and virus strain infection and application |
| 08/08/2007 | CN101012279A Vitelline antibody for resisting king cobra poison and its preparing method and use |
| 08/08/2007 | CN101011574A Use of an anti-il6 receptor antibody for preparing pharmaceutical composition |
| 08/08/2007 | CN101011571A Use of GADD45 beta protein and its inhibitor in treatment of rheumatoid arthritis |
| 08/07/2007 | US7253275 Neutralizing epitopes; induce immunology response |
| 08/07/2007 | US7253270 Polynucleotide encoding a mutated HIV gp41 polypeptide |
| 08/07/2007 | US7253263 Complementarity determining region-grafted antibody against ganglioside GD3 and derivative of antibody against ganglioside GD3 |
| 08/07/2007 | US7253159 Antigen and lysine acylated protein; cytokines; drug screening; liquid chromatography |
| 08/07/2007 | US7253151 Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant |
| 08/07/2007 | US7252996 Ancillary composition for the preparation of committed mature dentritic cells |
| 08/07/2007 | US7252994 Human DR4 antibodies and uses thereof |
| 08/07/2007 | US7252984 La Sota strain of the virus having a mutation in the gene sequences coding for HN and/or F glycoprotein(s): genetic engineering; also administrable post-hatch; birds; poultry; veterinary medicine; infectious bronchitis and bursal disease; adenovirus, reovirus, pox diseases; laryngotracheitis; influenza |
| 08/07/2007 | US7252829 HLA binding peptides and their uses |
| 08/07/2007 | US7252828 For inducing active immunity to infections caused by Staphylococcus aureus, S. epidermidis |
| 08/07/2007 | US7252827 Fusion protein comprising an immunogenic polypeptide; treatment of Hepatitis CVirus infection and assays for the diagnosis of HCV |
| 08/07/2007 | US7252826 Modified mite allergen and pharmaceutical uses thereof |
| 08/07/2007 | US7252825 MAGE-3 peptides presented by HLA class II molecules |
| 08/07/2007 | US7252824 Anti-neovasculature preparations for cancer |
| 08/07/2007 | US7252823 Recombinant A2-specific TNFα-specific antibodies |
| 08/07/2007 | US7252822 Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist |
| 08/07/2007 | US7252821 Cancerous disease modifying antibodies |
| 08/07/2007 | US7252817 Administering viruses selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus to mammal having Ras-activated pathway to result in lysis of proliferating cells |
| 08/07/2007 | US7252799 Methods for sterilizing preparations containing albumin |
| 08/07/2007 | CA2424242C Methods for treating muscle injuries |
| 08/07/2007 | CA2381770C Human ctla-4 antibodies and their uses |
| 08/07/2007 | CA2286304C Pca3, pca3 genes, and methods of use |
| 08/07/2007 | CA2182888C Nucleotide and amino acid sequences of canine herpesvirus gb, gc and gd and uses therefor |
| 08/07/2007 | CA2115565C Methods and compositions relating to useful antigens of moraxella catarrhalis |
| 08/07/2007 | CA2071863C Recombinant vaccine for porcine pleuropneumonia |
| 08/07/2007 | CA2062829C Nucleotides sequences derived from the genome of type hiv-1, hiv-2 and siv retroviruses, and their applications especially for the amplification the genomes of these retroviruses and for in vitro diagnosis of infections due to these viruses |
| 08/02/2007 | WO2007087457A2 Combination therapy for the treatment of neovascular disorders |
| 08/02/2007 | WO2007087453A2 Compositions and methods for treating haematological proliferative disorders |
| 08/02/2007 | WO2007087418A2 Composition and method for neuromuscular blockade |
| 08/02/2007 | WO2007087412A2 Tat-036 and methods of assessing and treating cancer |
| 08/02/2007 | WO2007087370A2 Tat-038 and methods of assessing and treating cancer |
| 08/02/2007 | WO2007087367A2 Methods and compositions for modulating the mobilization of stem cells |
| 08/02/2007 | WO2007087341A2 Tolerogenic biodegradable artificial antigen presenting system |
| 08/02/2007 | WO2007087289A2 Anti-fcrn antibodies for treatement of auto/allo immune conditions |
| 08/02/2007 | WO2007087266A2 Methods and compositions of targeted drug development |
| 08/02/2007 | WO2007087064A2 Pneumococcal serotypes |
| 08/02/2007 | WO2007086994A1 Single chain fragment of monoclonal antibody 9b9 and uses thereof |
| 08/02/2007 | WO2007086932A2 Prostate stem cell antigen vaccines and uses thereof |
| 08/02/2007 | WO2007086526A1 Gene polymorphism and use thereof |
| 08/02/2007 | WO2007086490A1 Remedy for disease associated with choroidal angiogenesis |
| 08/02/2007 | WO2007085815A2 Ligands that bind il-4 and/or il-13 |
| 08/02/2007 | WO2007085648A1 Tumour vaccine comprising allogeneic or xenogeneic tumour cells |
| 08/02/2007 | WO2007085567A2 Synergistic compositions for treating hiv |
| 08/02/2007 | WO2007085459A2 Method for the in vitro diagnosis of chlamydophila pneumoniae infections |
| 08/02/2007 | WO2007059461A3 Adenoviral vector-based foot-and-mouth disease vaccine |
| 08/02/2007 | WO2007056114A3 Compositions and methods for the detection of trypanosoma cruzi infection |
| 08/02/2007 | WO2007053176A3 Method of protecting against staphylococcal infection |
| 08/02/2007 | WO2007047728A3 Compositions and methods for the treatment of canine influenza virus disease |
| 08/02/2007 | WO2007045927A3 Therapeutic agent |
| 08/02/2007 | WO2007044024A3 Recombinant influenza vectors with tandem transcription units |
| 08/02/2007 | WO2007042326A3 Neisseria meningitidis antigens |
| 08/02/2007 | WO2007040653A3 Anti-cd30 antibodies that bind to intact cd30 but not soluble cd30 |
| 08/02/2007 | WO2007038117A3 Detecting foot-and-mouth disease virus |
| 08/02/2007 | WO2007036745A3 Interleukin-13 antibody composition |
| 08/02/2007 | WO2007035530A3 Ancestral dengue virus envelope protein sequence |
| 08/02/2007 | WO2007034166A3 Adjuvanted vaccine |
| 08/02/2007 | WO2007019620A8 Engineered antibodies with new world primate framework regions |
| 08/02/2007 | WO2007015783A3 Attenuated strains of flaviviruses , and uses thereof |
| 08/02/2007 | WO2007008712A3 Anti-alpha v beta 6 antibodies and uses thereof |
| 08/02/2007 | WO2007005144A3 Improved allergen-specific immunotherapy |
| 08/02/2007 | WO2006084129A3 Genes of porphyromonas gingivalis w83 involved in invasion of human cells |
| 08/02/2007 | WO2006068867A9 Combination therapy for b cell disorders |
| 08/02/2007 | WO2006041970A3 Treatment of respiratory syncytial virus (rsv) infection |
| 08/02/2007 | WO2006029045A3 Endothelial cell specific antibodies and uses thereof |